Northpond Ventures III, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX)

Filing Manager
Northpond Ventures III, LP
Reporting Manager
Michael P. Rubin
Security
Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
KYTX
Shares outstanding
56,833,213 shares
Disclosed Ownership
3,466,826 shares
Ownership
6.1%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 18:51:57 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Northpond Ventures III, LP 4.9% 2,805,426 0 2,805,426 /s/ Patrick Smerkers By Northpond Ventures III GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures III GP, LLC 4.9% 2,805,426 0 2,805,426 /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Northpond Ventures, LP 0.8% 450,000 0 450,000 /s/ Patrick Smerkers By Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures GP, LLC 0.8% 450,000 0 450,000 /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
NPV Listed, LLC 0.4% 211,400 0 211,400 /s/ Patrick Smerkers By Northpond Ventures, LLC, its Manager, By Patrick Smerkers, Authorized Signatory
Northpond Ventures, LLC 0.4% 211,400 0 211,400 /s/ Patrick Smerkers By Patrick Smerkers, CFO, Partner
Michael P. Rubin 6.1% 3,466,826 0 3,466,826 /s/ Michael P. Rubin Michael P. Rubin